If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCom.int.bk.regs Regulatory News (CBKD)

Share Price Information for Com.int.bk.regs (CBKD)

Share Price is delayed by 15 minutes
Get Live Data
2.73    0.05 (1.87%)
Bid:
2.68
Ask:
2.69
Spread: 0.01 (0.373%)
Market Cap: $9.01b
CBKD Live PriceLast checked at - London Stock Exchange

Intraday Com.int.bk.regs Share Chart

  • This share is an international stock.

Annual Financial Report

1 Feb 2018 07:00

RNS Number : 5681D
Commercial Intnl Bank (Egypt) SAE
01 February 2018
Β 

Commercial International Bank (Egypt) S.A.E.

Consolidated Financial Statements

December 31st , 2017

Click on, or paste the following link into your web browser, to view the associated PDF document.http://www.rns-pdf.londonstockexchange.com/rns/5681D_-2018-2-1.pdf

Β 

Β 

Β 

Β 

Β 

Β 

Β 

FINANCIAL POSITION

As of December 31st, 2017

Amounts in EGP Thousands

Note

December 31st, 2017

December 31st , 2016

Β 

Assets

Cash and balances with central bank

15

14,663,289

10,522,040

Due from banks

16

45,319,766

58,011,034

Treasury bills and other governmental notes

17

54,478,202

39,177,184

Trading financial assets

18

7,295,197

2,445,134

Loans and advances to banks, net

19

1,313

159,651

Loans and advances to customers, net

20

88,427,103

85,224,148

Non current assets held for sale

42

-

4,890,438

Derivative financial instruments

21

40,001

269,269

Financial investments

- Available for sale

22

30,474,781

5,447,291

- Held to maturity

22

45,167,722

53,924,936

Investments in associates

23

65,039

36,723

Other assets

24

6,886,607

5,434,563

Intangible assets

41

368,923

499,131

Deferred tax assets (Liabilities)

32

179,630

181,308

Property, plant and equipment

25

1,414,519

1,320,905

Total assets

294,782,092

267,543,755

Liabilities and equity

Liabilities

Due to banks

26

1,877,918

3,008,996

Due to customers

27

250,723,052

231,740,795

Non current liabilities held for sale

42

-

3,684,676

Derivative financial instruments

21

196,984

331,091

Current tax liabilities

2,778,973

2,017,034

Other liabilities

29

5,476,531

3,579,330

Long term loans

28

3,674,736

160,243

Other provisions

30

1,615,159

1,514,057

Total liabilities

266,343,353

246,036,222

Equity

Issued and paid up capital

31

11,618,011

11,538,660

Reserves

34

8,725,966

3,451,756

Reserve for employee stock ownership plan (ESOP)

489,334

343,460

Retained earnings (losses)

89,873

31,462

Total equity

20,923,184

15,365,338

Net profit for the period/year

7,515,555

6,009,118

Total equity and net profit for the period/year

28,438,739

21,374,456

Minority interest

-

133,077

Total minority interest , equity and net profit for the period

28,438,739

21,507,533

Total liabilities, equity, minority interest and net profit for the period

Β 

294,782,092

267,543,755

INCOME STATEMENT

As of December 31st , 2017

Amounts in EGP Thousands

Note

December 31st , 2017

Β 

December 31st 0, 2016

Β 

Continued Operations

Interest and similar income

28,671,170

19,144,218

Interest and similar expense

(16,167,155)

(9,126,512)

Net interest income

6

12,504,015

10,017,706

Fee and commission income

2,676,944

1,965,529

Fee and commission expense

(624,278)

(417,573)

Net fee and commission income

7

2,052,666

1,547,956

Dividend income

8

34,514

34,236

Net trading income

9

1,292,215

1,315,182

Profits on financial investments

22

165,111

(25,533)

Administrative expenses

10

(3,112,508)

(2,432,652)

Other operating (expenses) income

11

(1,063,468)

(1,237,187)

Goodwill impairment

-

(209,842)

Intangible assets amortization

41

(130,208)

(130,208)

Impairment charge for credit losses

12

(1,742,281)

(892,874)

Bank's share in the profits of associates

29,066

2,989

Profit before income tax

10,029,122

7,989,773

Income tax expense

13

(2,778,973)

(2,017,034)

Deferred tax assets (Liabilities)

32 & 13

(1,678)

(76,849)

Net profit from continued operations

7,248,471

5,895,890

Net profit from discontinued operations

Β 

122,234

127,376

Profit (loss) of disposal from discontinued operations

43

168,900

-

Net profit for the period

7,539,605

6,023,266

Minority interest

24,050

14,148

Bank shareholders

7,515,555

6,009,118

Earnings per share

14

Basic

5.76

4.54

Diluted

5.67

4.47

Β 

CASH FLOW STATEMENT

As of December 31st , 2017

Β 

Β 

Β 

Amounts in EGP Thousands

Β 

December 31st , 2017

December 31st , 2016

Cash flow from operating activities

Profit before income tax from continued operations

10,029,122

7,989,773

Profit before income tax from discontinued operations

-

158,041

Adjustments to reconcile net profit to net cash provided by operating activities

Fixed assets depreciation

351,005

285,381

Impairment charge for credit losses

1,742,281

892,874

Other provisions charges

212,622

150,847

Trading financial investments revaluation differences

(248,072)

(269,283)

Available for sale and held to maturity investments exchange revaluation differences

100,078

(2,219,961)

Goodwill impairment

-

209,842

Intangible assets amortization

130,208

130,208

Financial investments impairment charge

(83,079)

82,428

Utilization of other provisions

(25,463)

(3,696)

Other provisions no longer used

(97,897)

(78,405)

Exchange differences of other provisions

11,840

583,550

Profits from selling property, plant and equipment

(607)

(1,682)

Profits from selling financial investments

99,047

(35,193)

Profits from selling investments in associates

-

90,447

Impairment (Released) charges of Associates

(9,570)

(131,799)

Shares based payments

290,884

187,000

Bank's share in the profits of associates

(38,636)

-

Associates Financial Investments Revaluation Differences

-

2,989

Operating profits before changes in operating assets and liabilities

12,463,763

Β 

8,023,361

Β 

Net decrease (increase) in assets and liabilities

Due from banks

(2,594,442)

264,072

Treasury bills and other governmental notes

(16,466,420)

(16,057,258)

Trading financial assets

(4,601,991)

3,672,526

Derivative financial instruments

95,161

(2,918)

Loans and advances to banks and customers

(4,019,132)

(29,440,654)

Other assets

(1,121,981)

(4,450,111)

Non current assets held for sale

428,011

-

Due to banks

(1,131,078)

1,408,227

Due to customers

18,802,058

76,506,379

Income tax obligations paid

(2,017,034)

(1,949,694)

Other liabilities

1,897,201

4,354,673

Net Cash Provided from operating activities

1,734,116

42,328,603

Cash flow from investing activities

Proceeds from redemption of subsidiaries and associates

750

(12,036)

Payment (Proceeds) for purchases and sell of subsidiary and associates

(44,318)

176,161

Payment for purchases of property, plant, equipment and branches constructions

(745,089)

(560,631)

Proceeds from redemption of held to maturity financial investments

13,354,468

4,094

Payment for purchases of held to maturity financial investments

(4,597,254)

(1,243,669)

Payment for purchases of available for sale financial investments

(25,868,230)

(3,334,122)

Proceeds from selling available for sale financial investments

973,963

2,946,710

Proceeds from selling non-current assets held for sale

628,521

(2,989)

Β 

Net cash used in investing activities

Β 

(16,297,189)

Β 

(2,026,482)

Β 

Cash flow from financing activities

Increase (decrease) in long term loans

3,524,063

28,915

Dividend paid

(1,350,204)

(1,463,450)

Capital Increase

79,351

68,057

Net cash used in financing activities

2,253,210

(1,366,478)

Β 

Net increase (decrease) in cash and cash equivalent during the year

(12,309,863)

38,935,643

Beginning balance of cash and cash equivalent

61,518,700

22,583,057

Cash and cash equivalent at the end of the year

49,208,837

61,518,700

Cash and cash equivalent comprise:

Cash and balances with central bank

14,663,289

10,522,040

Due from banks

45,319,766

58,011,034

Treasury bills and other governmental notes

54,478,202

39,177,184

Obligatory reserve balance with CBE

(8,878,986)

(5,438,235)

Due from banks with maturities more than three months

(1,719,586)

(2,565,895)

Treasury bills with maturity more than three months

(54,653,848)

(38,187,428)

Total cash and cash equivalent

49,208,837

61,518,700

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

COMMERCIAL INTERNATIONAL BANK (EGYPT) S.A.E

Β 

Consolidated statement of changes in shareholders' equity for the period ended on December 31st, 2016

Dec. 31, 2016

Issued and paid up capital

Legal reserve

General reserve

Retained earnings (losses)

Special reserve

Reserve For A.F.S investments revaluation diff.

Banking risks reserve

IFRS 9 risk reserve

Net profit for the year

Reserve for employee stock ownership plan

Cumulative foreign currencies translation differences

Total Shareholders Equity

Minority Interest

Total

EGP Thousands

Beginning balance

11,470,603

803,355

1,518,373

(64,566)

30,214

(2,202,462)

2,513

-

4,728,976

248,148

-

16,535,154

47,431

16,582,585

Capital increase

68,057

-

-

-

-

-

-

-

-

-

-

68,057

-

68,057

Transferred to reserves

-

232,008

3,035,878

-

564

-

-

-

(3,176,762)

(91,688)

-

-

-

-

Transferred to retained earnings (losses)

-

-

-

88,258

-

-

-

-

(88,258)

-

-

-

-

-

Dividend paid

-

-

-

(3,896)

-

-

-

-

(1,463,450)

-

-

(1,467,346)

(1,394)

(1,468,740)

Net profit of the year

-

-

-

-

-

-

-

-

6,009,118

-

-

6,009,118

14,148

6,023,266

Change in ownership percentage

-

-

-

11,666

-

-

-

-

-

-

-

11,666

72,892

84,558

Net unrealised gain/(loss) on AFS

-

-

-

-

-

22,219

-

-

-

-

-

22,219

-

22,219

Transferred (from) to bank risk reserve

-

-

-

-

-

-

506

-

(506)

-

-

-

-

-

Cost of employees stock ownership plan (ESOP)

-

-

-

-

-

-

-

-

-

187,000

-

187,000

-

187,000

Cumulative foreign currencies translation differences

-

-

-

-

-

-

-

-

-

-

8588

8,588

-

8,588

Balance at the end of the year

11,538,660

1,035,363

4,554,251

31,462

30,778

(2,180,243)

3,019

-

6,009,118

343,460

8,588

21,374,456

133,077

21,507,533

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Consolidated statement of changes in shareholders' equity for the period ended on December 31st, 2017

Β 

Β 

Β 

Β 

Β 

Β 

Dec. 31, 2017

Issued and paid up capital

Legal reserve

General reserve

Retained earnings (losses)

Special reserve

Reserve For A.F.S investments revaluation diff.

Banking risks reserve

IFRS 9 risk reserve

Net profit for the year

Reserve for employee stock ownership plan

Cumulative foreign currencies translation differences

Total Shareholders Equity

Minority Interest

Total

Β 

EGP Thousands

Β 

Β 

Beginning balance

11,538,660

1,035,363

4,554,251

31,462

30,778

(2,180,244)

3,019

-

6,009,118

343,460

8,588

21,374,455

133,077

21,507,532

Β 

Capital increase

79,351

-

-

-

-

-

-

-

-

-

-

79,351

-

79,351

Β 

Transferred to reserves

-

297,444

4,445,620

58,563

1,682

-

-

-

(4,658,299)

(145,010)

-

-

-

-

Β 

Dividend paid

-

-

-

-

-

-

-

-

(1,350,204)

-

-

(1,350,204)

-

(1,350,204)

Β 

Net profit for the year

-

-

-

-

-

-

-

-

7,515,555

-

-

7,515,555

24,050

7,539,605

Β 

Disposal of subsidiary

-

-

152

(152)

-

-

-

-

-

-

(8,588)

(8,588)

-

(8,588)

Β 

Change in ownership percentage

-

-

-

-

-

-

-

-

-

-

-

-

(157,127)

(157,127)

Β 

Net unrealised gain/(loss) on AFS

-

-

-

-

-

537,286

-

-

-

-

-

537,286

-

537,286

Β 

Transferred (from) to bank risk reserve

-

-

-

-

-

-

615

-

(615)

-

-

-

-

-

Β 

IFRS 9 risk reserve

-

-

-

-

-

-

-

1,411,549

(1,411,549)

-

-

-

-

-

Β 

Cost of employees stock ownership plan (ESOP)

-

-

-

-

-

-

-

-

-

290,884

-

290,884

-

290,884

Β 

Balance at the end of the year

11,618,011

1,332,807

9,000,023

89,873

32,460

(1,642,958)

3,634

1,411,549

6,104,006

489,334

-

28,438,739

-

28,438,739

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
FR FKDDDABKKQBK
Date   Source Headline
12th May 202610:18 amRNS1st Quarter Results
12th May 202610:16 amRNSCIB Consolidated Financial Statements 1Q26
12th May 202610:15 amRNS1Q26 Earnings Release
16th Mar 20267:00 amRNSResolutions Ordinary General Assembly March 2026
16th Mar 20267:00 amRNSResolutions Extraordinary GA March 2026
16th Mar 20267:00 amRNSResolutions Extraordinary GA March 2026
16th Mar 20267:00 amRNSResolutions Ordinary General Assembly March 2026
24th Feb 202612:31 pmRNSItems of Extraordinary GA
24th Feb 20267:00 amRNSPress Release dated 23th February 2026
19th Feb 20261:20 pmRNSItems of Extraordinary GA
19th Feb 20261:17 pmRNSInvitation to the Extraordinary GA 2026
19th Feb 20268:00 amRNSItems of OGA 2026
19th Feb 20268:00 amRNSInvitation to the OGA March 15
10th Feb 20267:00 amRNSCIB Summary of Board Resolution 9 Feb 2026
10th Feb 20267:00 amRNSFY25 Earnings Release
10th Feb 20267:00 amRNSCIB IFRS Consolidated Financial Statements FY25
15th Dec 20257:00 amRNSChange in Board of Directors
3rd Dec 20254:35 pmRNSCIB Bonus Shares Distribution 2025
4th Nov 20257:00 amRNSCIB Condensed Consolidated 3rd Quarter Results
4th Nov 20257:00 amRNSCIB 9M25 Earnings Release
4th Nov 20257:00 amRNS3rd Quarter Results
25th Sep 20253:55 pmRNSSummary of Resolutions - GAM September 2025
1st Sep 20257:02 amRNSInvitation to General Assembly September 2025
22nd Jul 20257:00 amRNSCIB 1H2025 Condensed Consolidated Financials
22nd Jul 20257:00 amRNSCIB 1H2025 Condensed Separate Financials
22nd Jul 20257:00 amRNS2Q25 Earnings Release
28th May 20256:00 pmRNSChanges to the Board of Directors
13th May 20257:00 amRNSSeparate- Q12025
13th May 20257:00 amRNS1Q25 Press Release
13th May 20257:00 amRNSConsolidated Financial Position at March 31.2025
24th Mar 20257:00 amRNSOrdinary General Assembly Resolutions Summary 2025
28th Feb 20257:00 amRNSGeneral Assembly 2025 - Discussion Items - amended
27th Feb 20257:47 amRNSInvitation to General Assembly 2025
27th Feb 20257:15 amRNSGeneral Assembly 2025 - Discussion Items
19th Feb 20257:00 amRNSCIB Annual Financial Report
19th Feb 20257:00 amRNSCIB FY2024 Earnings Release
6th Nov 20247:58 amRNSCIB gets regulatory approvals to changes to BoD
4th Nov 20247:00 amRNSEarnings Release 3Q.2024
4th Nov 20247:00 amRNSCIB-Separate Financial Statements 3Q.2024
4th Nov 20247:00 amRNSCIB-Consolidated Financial Statements 3Q.2024
1st Oct 20242:00 pmRNSCIB obtaining Long term loan from IFC
16th Sep 20248:00 amRNSChanges in CIB's Board of Directors
22nd Jul 20247:00 amRNSCIB H1-2024 Separate Financial Statements - E
22nd Jul 20247:00 amRNSH1.2024 Press Release
22nd Jul 20247:00 amRNSCIB H1-2024 Consolidated Financial Statements
13th May 20247:00 amRNS1st Quarter Results - Separate Statements
13th May 20247:00 amRNS1st Quarter Results - Consolidated Statements
26th Mar 20247:49 amRNSChanges in CIB's BOD - 25 March 2024
26th Mar 20247:00 amRNSOGM Resolutions - March 25th, 2024
26th Mar 20247:00 amRNSEGM Resolutions - March 25th, 2024

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.